Related Experiment Video
Updated: May 31, 2025

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil
Published on: July 29, 2020
Hospitalization and mortality in children due to COVID-19. A retrospective study from Brazil
Ana Carolina Pereira de Godoy1, Reinaldo Bugarelli Bestetti2
1Hospital da Criança e Materinade de Sao Jose do Rio Preto-Brazil, Rua Floriano Peixoto 2950, Sao Jose do Rio Preto, BR.
Insights
COVID-19 mortality was significantly lower in children and adolescents (3.13%) compared to adults (25.4%). Most pediatric deaths were linked to pre-existing conditions, highlighting the importance of comorbidities in severe COVID-19 outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- COVID-19 poses a significant global health challenge, affecting all age groups.
- Children are as susceptible to COVID-19 infection as adults.
Purpose of the Study:
- To compare COVID-19 mortality rates between individuals under 19 years old and adults.
- To identify factors associated with mortality in pediatric COVID-19 cases.
Main Methods:
- Retrospective, observational study of COVID-19 patients hospitalized in São Jose do Rio Preto, Brazil.
- Analysis of medical records for 8986 patients, including 383 under 19 (Group I) and 8603 adults (Group II).
- COVID-19 diagnosis confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR).
Main Results:
- Overall COVID-19 mortality was substantially higher in adults (25.4%) than in children and adolescents (3.13%) (p < 0.0001).
- Of the 12 pediatric deaths, 11 had associated comorbidities.
- Mortality rates varied by age group within the pediatric cohort, with the highest in 15-19 year olds (5.13%).
Conclusions:
- COVID-19 mortality is significantly lower in pediatric populations compared to adults.
- Comorbidities play a crucial role in the mortality of children and adolescents with COVID-19.
Background:
Background: COVID-19 is currently one of the most important medical challenges as it affects the entire population, with children being infected as easily as adults.
Objective:
The objective of this study was to evaluate the prevalence of mortality in under 19-year-old individuals compared to that of adults.
Methods:
This retrospective, observational study analyzed the medical records of all patients diagnosed with COVID-19 by real-time reverse transcription-polymerase chain reaction (RT-PCR) who were hospitalized at Hospital de Base and the Infant and Maternal Hospital of São Jose do Rio Preto, SP, Brazil. Of a total of 8986 hospitalized COVID-19 positive patients, 383 were under 19 years old (Group I) and 8603 were adults (Group II).
Results:
Overall mortality was significantly higher (p-value < 0.0001) in Group II (n = 2185; 25.4%) compared to Group I (n = 12; 3.13%). Eleven of the 12 patients of Group I that died had associated diseases. The number of deaths of under 1-year-old infants was 2/123 (1.63%), of 1- to 4-year-old children it was 4/95 (4.21%), of 5- to 9-year-old children it was 1/47 (2.13%), of 10- to 14-year-old adolescents it was 1/40 (2.50%) and of 15- to 19-year-old adolescents it was 4/78 (5.13%).
Conclusions:
Mortality from COVID-19 in children and adolescents was significantly lower than in adults and associated with other comorbidities.
Related Concept Videos
Hospitals-I
Hospitals-II
Nurses that work in...
Pneumonia III: Complications and Assessment
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

